Grzegorz Koscielniak
General Compute’s AI Inference Valuation Surge
General Compute Raises $100M Series A at Reported $800M Valuation for Inference Infrastructure General Compute announced a $100 million Series A on 27 October 2026, co-led by Blackbird and Abstract, with Fuse Venture Partners, Village Global and others participating. The company finances, deploys and operates GPUs and specialised inference chips,
Bedrock Robotics’ $4.1B Bet on Autonomous Construction
Bedrock Robotics Raises $600M at $4.1B Valuation as Autonomous Excavators Perform Paid Work Bedrock Robotics announced a $600 million Series C on 26 October 2026 at a $4.1 billion post-money valuation. CapitalG and Emergence Capital co-led the round, bringing total funding to nearly $1 billion. The company says
Warhound: Gene-Engineered Military Dogs Meet Defense Tech
A Billion-Dollar Bet on Working Dogs The Wall Street Journal reported that the first puppies are expected in the first quarter of 2027. Births would be an initial development milestone, rather than evidence of completed training or readiness for service. Invest in top private AI companies before IPO, via a
Warp Sciences: AI and Robotics for Drug Discovery Labs
Warp Sciences Launches With $215M to Build AI-Enabled Chemistry Services Warp Sciences emerged from stealth on 22 October 2026 with $215 million in funding led by Lightspeed. Participants included Premji Invest, Mayfield, IVP, Lux and Menlo Ventures. The company is building a US-based chemistry contract research organisation combining chemists, AI
Warhound’s $200M Bet on Genetically Enhanced Working Dogs
Warhound Announces $200M Seed Funding at Reported $1.2B Valuation for Working-Dog Programme Warhound emerged from stealth on 22 October 2026, announcing $200 million in seed funding. Axios reported a $1.2 billion post-money valuation. The company plans to combine genetics, cloning, training and Anduril equipment to develop working dogs.
Flapping Airplanes’ $6 Billion AI Efficiency Bet
Flapping Airplanes Raises $1B Series A at Reported $6B Valuation for AI Efficiency Research Flapping Airplanes announced a $1 billion Series A on 21 October 2026, co-led by Index Ventures and Lux Capital. Bloomberg reported a $6 billion post-money valuation, four times its previous $1.5 billion valuation. The financing
Pigment’s $250M Series E Signals AI’s Move Into Enterprise Planning
Pigment Announces $250M Series E at $2.3B Valuation as Reported ARR Exceeds $100M Pigment announced a $250 million Series E on 21 October 2026 at a $2.3 billion valuation. Scaleup Europe Fund, managed by EQT, led the round, with World Innovation Lab and existing investors participating. NVIDIA’s
Neolix’s $400M Bet on Scaling Driverless Delivery
Neolix Raises Nearly $400M as Reported Autonomous Delivery Fleet Exceeds 30,000 Neolix announced nearly $400 million in Series E financing on 20 October 2026 to support international expansion and autonomous-delivery development. Reporting identifies Boyu Capital and a national-level investment fund as co-leads. The financing demonstrates investor commitment, rather than
Tenstorrent’s $1.5B Raise Signals an Open AI Infrastructure Challenge to Nvidia
Tenstorrent Raises $1.5B Series E at $6.2B Valuation to Expand AI Computing Tenstorrent announced on 19 October 2026 that it had closed a $1.5 billion Series E at a $6.2 billion post-money valuation. Trace Capital and Innovation X led the round. The company says the capital
Saronic’s Shift From Autonomous Boat Prototype to Scaled Naval Production
Saronic Wins US Navy Production Contract for Marauder Autonomous Vessels Saronic announced in late September 2026 that it had received a firm-fixed-price production award under the US Navy’s Medium Unmanned Surface Vessel Marketplace for Marauder, its 180-foot autonomous vessel. The award provides evidence of customer commitment, but does not
Shield AI’s Hivemind Slashes Autonomous Flight Development Time
Honeywell Reports First Autonomous Flight After Six Weeks Using Shield AI’s Hivemind Honeywell Aerospace and Shield AI announced on 13 October 2026 that Honeywell engineers achieved their first autonomous flight six weeks after beginning Hivemind Enterprise training. Engineering leads had estimated that comparable development would normally take 54 weeks.
Hadrian’s Lockheed Deal Signals a New Era in Defense Manufacturing Automation
Hadrian Signs Seven-Year Lockheed Martin Agreement for Automated Manufacturing Hadrian announced a seven-year agreement with Lockheed Martin on 14 October 2026 to bring automated manufacturing capabilities into its Missiles and Fire Control facility in Grand Prairie, Texas. The agreement builds on a memorandum of understanding announced in December 2025 and
AI Drug Discovery Partnership: insitro and AstraZeneca’s $1.5B Bet
Insitro Signs AstraZeneca AI Drug-Discovery Collaboration Worth Up to $1.5B Insitro announced a discovery collaboration with AstraZeneca on 15 October 2026 covering metabolic dysfunction-associated steatohepatitis (MASH) and cardiomyopathies. The agreement provides for $40 million upfront and up to approximately $1.46 billion in contingent milestones, plus royalties. Invest in
Modal’s AI Infrastructure Surge
Modal Raises $750M Series D at $15.75B Valuation as Annualised Run Rate Tops $1B Modal announced a $750 million Series D on 14 October 2026 at a $15.75 billion post-money valuation. Accel led the round, with Kleiner Perkins and existing investors participating. The valuation is approximately 3.4
ICON’s $200M Bet on 3D-Printed Homebuilding Scale
ICON Raises $200M Series D to Expand Robotic Construction Systems for Builders CON announced a $200 million Series D on 13 October 2026, co-led by Baillie Gifford and funds managed by BlackRock. The company says the financing will support manufacturing and deployment of its robotic construction systems, research facilities and
CMR Surgical’s $400M Stryker Alliance
Stryker Announces $400M CMR Surgical Investment and Exclusive US Sales Alliance Stryker and CMR Surgical announced a strategic alliance on 12 October 2026, including an approximately $400 million preferred-equity investment, an exclusive US sales agency agreement for the Versius portfolio and an exclusive option for Stryker to acquire CMR’s
Amazon, Decart, and the $7B Bet on AI Infrastructure
Amazon Reportedly Discusses $7B Acquisition of Decart Amazon is reportedly in talks to acquire Decart in a transaction that could value the AI company at around $7 billion, according to The Wall Street Journal, as reported by Reuters on 11 October 2026. No completed agreement has been announced, and negotiations
TypeSafe AI’s Breakout Funding for Decision-Focused Enterprise AI
A Funding Explosion That Turned Heads TypeSafe AI announced an $870 million Series A at a $7.5 billion valuation on 9 October 2026, 24 days after Jev’s early-access launch. Andreessen Horowitz led the round, with Sequoia Capital and existing investor DCVC participating. The financing indicates substantial investor interest,
Ultra’s Warehouse Robots Move From Hype to Real Orders
Ultra Raises $50M Series A as Warehouse Robots Pack Over 500,000 Orders Ultra has raised a $50 million Series A, bringing its total announced funding to $62 million. The warehouse robotics company says its robots have packed more than 500,000 orders. These milestones indicate financing support and operating
Oratomic’s $5.4B Quantum Leap in Private Markets
Quantum Computing Has Entered a New Capital Era Oratomic has reportedly raised $475 million in a Series B at a $5.4 billion valuation, compared with $1.5 billion following its Series A roughly three months earlier, according to The Wall Street Journal. On 8 October 2026, the company confirmed
Lambda’s AI Cloud Backlog Surge and Pre-IPO Funding Push
Lambda Reportedly Seeks Up to $4B as Backlog Reaches $50B Lambda is reportedly raising up to $4 billion in a round led by Blackstone and Coatue Management at a $14.5 billion pre-money valuation. Reuters, citing The Wall Street Journal, reported that Lambda is targeting a 2027 IPO, subject to
Multiply Labs’ $75M Bet on AI-Powered Biomanufacturing
Multiply Labs Raises $75M to Expand Robotic Biomanufacturing Manufacturing is a significant constraint on the scale and affordability of some advanced therapies. Multiply Labs is developing robotic systems intended to automate complex production workflows using manufacturers’ existing instruments. AI is increasingly used in drug discovery, but translating a candidate into